Tvardi Therapeutics (TVRD) Inventory (2021 - 2025)
Tvardi Therapeutics (TVRD) posted Inventory of $2.4 million for Q1 2025, up 168.33% sequentially from $900000.0 in Q4 2024, and down 13.32% YoY from $2.8 million in Q1 2024.
Tvardi Therapeutics (TVRD) Inventory (2021 - 2025) Analysis & Trends
Tvardi Therapeutics has reported Inventory for 5 years, with the latest figure at $2.4 million in Q1 2025.
- Quarterly Inventory fell 13.32% year-over-year to $2.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $2.4 million (down 13.32% YoY) and the FY2024 annual result came in at $900000.0, down 73.11% from the prior year.
- Inventory rose to $2.4 million in Q1 2025 per TVRD's latest filing, from $900000.0 in the prior quarter.
- Over five years, Inventory peaked at $3.5 million in Q1 2023 and troughed at $900000.0 in Q4 2024.
- A 5-year average of $2.5 million and a median of $2.5 million in 2021 frame the typical range for Inventory.
- The sharpest annual moves came in 2023 and 2024: Inventory soared 84.32% in 2023, then tumbled 73.11% in 2024.
- Over 5 years, Inventory stood at $2.6 million in 2021, then slipped by 7.78% to $2.4 million in 2022, then jumped by 40.45% to $3.3 million in 2023, then sank by 73.11% to $900000.0 in 2024, then jumped by 168.33% to $2.4 million in 2025.
- According to Business Quant data, Inventory over the past three periods registered $2.4 million, $900000.0, and $2.1 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 2.79 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 3.52 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 3.46 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 2.58 Mn |